medigraphic.com
ISSN 2007-462X (Print)
Organo de divulgación Científica de la Unidad Académica de Odontología de la Universidad Autónoma de Nayarit (UAN)

2020, Number 26

<< Back Next >>

Rev Tame 2020; 8.9 (26)

Hiperplasia gingival farmacoinducida

De León VFJ, Agustín CE, Fontes GZ, Bojorquez AY

Language: Spanish
References: 25
Page: 1056-1059
PDF size: 177.97 Kb.


ABSTRACT

It is well documented that the treatment of some cardiovascular diseases is carried out with drugs whose mechanism of action is based on the blockage of calcium channels; This group of drugs, especially nifedipine, has been shown to have a direct relationship with the development of a periodontal condition known as gingival hyperplasia. This clinical condition can compromise the function, aesthetics and hygiene of this type of patient. This report documents the clinical and histopathological diagnosis and the conventional treatment that was given to a patient who has been pharmacological for more than 30 years, managing to restore the physiological periodontal conditions of the patient and her hygiene control after treatment.


REFERENCES

  1. Kimball O, the treatment of epilepsy with sodium diphenylhydantoin, J Amer Med Ass. 112 (13); 1939.

  2. Ramon Y, Behar S, Kishen Y, Engelberg I, Gingival hyperplasia caused by nifedipine- a preliminary report, Int J Cardio.1981; 5(2): 195-204.

  3. Barclay S, Thomason J, Idle J, Seymour R, The incidence and severity of nifedipine-induced gingival overgrowth, J CLin Periodontol. 1992:19; 311-14.

  4. Carmargo P, Melnick P, Pirih F, Lagos R, Takei H, Treatment of drug- induced gingival enlargement: aesthetic and functional consideratios, Periodontol 2000. 2001; 27: 131-138.

  5. Mohan S, Nalluswami J, Sanghar S, Joseph I, Nifedipine- induced gingival enlargement correlation with dose and oral hygiene, Journal of pharmacy and bioallied sciences. 2012; 4 (Suppl 2 Part I): S191-S193.

  6. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M, Nifedipine-induced gingival hyperplasia, a comprehensive review and analysis, Oral Surg Med Oral Pathol Oral radio Ended. 1995; 79: 715-722

  7. Nery E, Edson R, Lee k, Pruthi V, Watson J, Prevalence of nifedipine-induced gingival hyperplasia, J periodontal. 1995; 66(7): 572-578.

  8. Hallmon W, Rossman J, The role of drugs in the pathogenesis of gingival overgrowth- A collective review of current concepts. Periodontol. 2000, 21: 176-196.

  9. Ballard JB, Butler W, Proteins of the periodontium, biochemical studies on collagen an non collagenous proteins of human gingiva, Periodontics. 1965;3:196-199. 10. Steele RM, Schuna AA, Screiber RT. Calcium antagonist- induced gingival hyperplasia. Ann Intern Med. 1994: 120: 663-664.

  10. Nery EB, Edson RG, Lee KK, Pruthi VJ, Watson J. Prevalence of nifedipine- induced hyperplasia. J periodontal. 1995:66: 572-578.

  11. Ellis JS, Seymour RA, Monkman SC, Idle JR. Deposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowth. J Periodontal Res. 1993: 28: 373-378.

  12. Seymour RA, Thomason JM, Ellis JS, the pathogenesis of drug- induced gingival overgrowth. J Clin Periodontol. 1996:23:165-175.

  13. Lainson PA. Gingival overgrowth in a patient treated with nifedipine (Procardia). Periodontal Case Rep. 1986:8:14-16.

  14. Seymour RA. Clacium channel blockers and gingival overgrowth. J Clin Periodontol 1994:21:281-283.

  15. Ramires F, Sun Y, Weber K, Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J Mollec and Cell Cardi. 1998; 30: 475-483.

  16. Fujii A, Matsumoto H, Nakao S, Teishigawara H, Akimoto Y. Effect of calcium channel blockers on cell proliferation, DNA synthesis and collagen synthesis of cultured gingival fibroblasts derived from human nifedipine responders and non responders. Arch Oral Bio. 1994: 39-104.

  17. Van Der Wall EE, Tuirizing DB, Hes J, Gingival hyperplasia induced by nifedipine, an arterial vasodilating drug, Oral Surg Oral Med Oral Pathol. 1985; 60:38-40.

  18. Barak S, Engelberg IS, Hiss J, Gingival hyperplasia caused by nifedipine-induced gingival overgrowth, J Clin Periodontol 1992:19:311-314.

  19. Tonetti M, Greenwell H, Kornman K, Staging and grading of periodontitis: Framework and proposal of a new classification and case definition, J Periodontol. 2018;89(Suppl1): S159-S172.

  20. Livada R, Shiloah J, Calcium channel blocker-induced gingival enlargement, Journal of human hypertension. 2014; 28:10-14..

  21. Mohan P, Sanghar J, Jai S, Joseph I, Nifedipine-induced gingival enlargement correlation with dose and oral hygiene, J Pharm Biolall Sci. 2012;4;191-193.

  22. Castro L, Elias L, Oton A, Long-term effects of nifedipine on human gingival epithelium: a histopathological and inmunohistochemical study, Journal of Oral Science. 2010; 52 (1): 55-62.

  23. Kaur G, Verhanne, Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol. 2010; 37;625-630.

  24. Sam G, Chakkalakkal S, Non surgical management of nifedipine induced gingival overgrowth. Case Reports in Dentistry. 2014; 8: 1-4.

  25. Manzur I, Diaz I, Agrandamiento gingival farmacoinducido serie de casos. Univ Salud. 2018;20(1); 89-96.




2020     |     www.medigraphic.com